NDC 63539-688 – Ibrance
Palbociclib 125 mg/1 · Tablet, Film Coated · Oral
Product NDC63539-688
Product details
- Brand name
- Ibrance
- Generic name
- palbociclib
- Labeler
- U.S. Pharmaceuticals
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA212436
- Marketed since
- March 30, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Palbociclib 125 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 63539-688-03 sample | 3 DOSE PACK in 1 CARTON (63539-688-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-688-07) | Mar 30, 2020 |
Other Ibrance products
- 0069-0187 Palbociclib 75 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc
- 0069-0188 Palbociclib 100 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc
- 0069-0189 Palbociclib 125 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc
- 0069-0284 Palbociclib 75 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 0069-0486 Palbociclib 100 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 0069-0688 Palbociclib 125 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 63539-284 Palbociclib 75 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals
- 63539-486 Palbociclib 100 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals